UPDATE: Bank of America Merrill Lynch Downgrades Nu Skin Enterprises

In a report published Friday, BofA Merrill Lynch analyst Olivia Tong downgraded Nu Skin Enterprises (NYSE: NUS ) from Buy to Neutral, with a $94.00 price objective. According to the report, earlier this week, an article in China's People's Daily suggested that NUS was engaging in improper selling practices